The Beauty Health Company
The Beauty Health Company (SKIN) Stock Competitors & Peer Comparison
See (SKIN) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKIN | $0.62 | -7.93% | 83.4M | -4.95 | -$0.13 | N/A |
| PG | $142.32 | -0.27% | 329.8B | 20.71 | $6.84 | +3.00% |
| UL | $57.26 | -0.14% | 122.6B | 18.50 | $3.04 | +4.04% |
| CL | $89.57 | +0.82% | 70.5B | 34.17 | $2.58 | +2.36% |
| KVUE | $17.20 | +0.03% | 32.8B | 20.36 | $0.84 | +4.86% |
| KMB | $96.62 | -0.05% | 31.8B | 18.55 | $5.17 | +5.27% |
| EL | $80.30 | -0.66% | 29B | -114.62 | -$0.70 | +1.73% |
| CHD | $96.65 | +2.11% | 22.3B | 30.94 | $3.04 | +1.27% |
| SGI | $63.21 | -1.99% | 13.2B | 25.08 | $2.50 | +0.99% |
| CLX | $92.29 | +1.22% | 10.9B | 14.71 | $6.15 | +5.46% |
Stock Comparison
SKIN vs PG Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, PG has a market cap of 329.8B. Regarding current trading prices, SKIN is priced at $0.62, while PG trades at $142.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas PG's P/E ratio is 20.71. In terms of profitability, SKIN's ROE is -0.09%, compared to PG's ROE of +0.31%. Regarding short-term risk, SKIN is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PG's competition here
SKIN vs UL Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, UL has a market cap of 122.6B. Regarding current trading prices, SKIN is priced at $0.62, while UL trades at $57.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas UL's P/E ratio is 18.50. In terms of profitability, SKIN's ROE is -0.09%, compared to UL's ROE of +0.36%. Regarding short-term risk, SKIN is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UL's competition here
SKIN vs CL Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, CL has a market cap of 70.5B. Regarding current trading prices, SKIN is priced at $0.62, while CL trades at $89.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas CL's P/E ratio is 34.17. In terms of profitability, SKIN's ROE is -0.09%, compared to CL's ROE of +4.75%. Regarding short-term risk, SKIN is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CL's competition here
SKIN vs KVUE Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, KVUE has a market cap of 32.8B. Regarding current trading prices, SKIN is priced at $0.62, while KVUE trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas KVUE's P/E ratio is 20.36. In terms of profitability, SKIN's ROE is -0.09%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, SKIN is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KVUE's competition here
SKIN vs KMB Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, KMB has a market cap of 31.8B. Regarding current trading prices, SKIN is priced at $0.62, while KMB trades at $96.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas KMB's P/E ratio is 18.55. In terms of profitability, SKIN's ROE is -0.09%, compared to KMB's ROE of +1.44%. Regarding short-term risk, SKIN is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KMB's competition here
SKIN vs EL Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, EL has a market cap of 29B. Regarding current trading prices, SKIN is priced at $0.62, while EL trades at $80.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas EL's P/E ratio is -114.62. In terms of profitability, SKIN's ROE is -0.09%, compared to EL's ROE of -0.06%. Regarding short-term risk, SKIN is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EL's competition here
SKIN vs CHD Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, CHD has a market cap of 22.3B. Regarding current trading prices, SKIN is priced at $0.62, while CHD trades at $96.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas CHD's P/E ratio is 30.94. In terms of profitability, SKIN's ROE is -0.09%, compared to CHD's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CHD's competition here
SKIN vs SGI Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, SGI has a market cap of 13.2B. Regarding current trading prices, SKIN is priced at $0.62, while SGI trades at $63.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas SGI's P/E ratio is 25.08. In terms of profitability, SKIN's ROE is -0.09%, compared to SGI's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SGI's competition here
SKIN vs CLX Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, CLX has a market cap of 10.9B. Regarding current trading prices, SKIN is priced at $0.62, while CLX trades at $92.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas CLX's P/E ratio is 14.71. In terms of profitability, SKIN's ROE is -0.09%, compared to CLX's ROE of +28.26%. Regarding short-term risk, SKIN is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CLX's competition here
SKIN vs NTCO Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, SKIN is priced at $0.62, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas NTCO's P/E ratio is -11.37. In terms of profitability, SKIN's ROE is -0.09%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NTCO's competition here
SKIN vs ELF Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, ELF has a market cap of 3.3B. Regarding current trading prices, SKIN is priced at $0.62, while ELF trades at $55.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas ELF's P/E ratio is 31.88. In terms of profitability, SKIN's ROE is -0.09%, compared to ELF's ROE of +0.11%. Regarding short-term risk, SKIN is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ELF's competition here
SKIN vs IPAR Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, IPAR has a market cap of 2.8B. Regarding current trading prices, SKIN is priced at $0.62, while IPAR trades at $87.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas IPAR's P/E ratio is 16.35. In terms of profitability, SKIN's ROE is -0.09%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, SKIN is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check IPAR's competition here
SKIN vs COTY Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, COTY has a market cap of 1.8B. Regarding current trading prices, SKIN is priced at $0.62, while COTY trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas COTY's P/E ratio is -3.31. In terms of profitability, SKIN's ROE is -0.09%, compared to COTY's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check COTY's competition here
SKIN vs SPB Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, SPB has a market cap of 1.8B. Regarding current trading prices, SKIN is priced at $0.62, while SPB trades at $77.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas SPB's P/E ratio is 15.04. In terms of profitability, SKIN's ROE is -0.09%, compared to SPB's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SPB's competition here
SKIN vs NWL Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, NWL has a market cap of 1.6B. Regarding current trading prices, SKIN is priced at $0.62, while NWL trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas NWL's P/E ratio is -5.73. In terms of profitability, SKIN's ROE is -0.09%, compared to NWL's ROE of -0.11%. Regarding short-term risk, SKIN is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NWL's competition here
SKIN vs EPC Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, EPC has a market cap of 734.8M. Regarding current trading prices, SKIN is priced at $0.62, while EPC trades at $16.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas EPC's P/E ratio is -69.33. In terms of profitability, SKIN's ROE is -0.09%, compared to EPC's ROE of -0.05%. Regarding short-term risk, SKIN is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EPC's competition here
SKIN vs HELE Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, HELE has a market cap of 525.9M. Regarding current trading prices, SKIN is priced at $0.62, while HELE trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas HELE's P/E ratio is -0.58. In terms of profitability, SKIN's ROE is -0.09%, compared to HELE's ROE of -0.95%. Regarding short-term risk, SKIN is more volatile compared to HELE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check HELE's competition here
SKIN vs EWCZ Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, SKIN is priced at $0.62, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, SKIN's ROE is -0.09%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, SKIN is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EWCZ's competition here
SKIN vs NUS Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, NUS has a market cap of 297.6M. Regarding current trading prices, SKIN is priced at $0.62, while NUS trades at $6.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas NUS's P/E ratio is 5.68. In terms of profitability, SKIN's ROE is -0.09%, compared to NUS's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NUS's competition here
SKIN vs PTNM Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, SKIN is priced at $0.62, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas PTNM's P/E ratio is 346.33. In terms of profitability, SKIN's ROE is -0.09%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, SKIN is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PTNM's competition here
SKIN vs ACU Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, ACU has a market cap of 156.6M. Regarding current trading prices, SKIN is priced at $0.62, while ACU trades at $41.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas ACU's P/E ratio is 17.72. In terms of profitability, SKIN's ROE is -0.09%, compared to ACU's ROE of +0.08%. Regarding short-term risk, SKIN is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ACU's competition here
SKIN vs SLSN Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, SLSN has a market cap of 85.5M. Regarding current trading prices, SKIN is priced at $0.62, while SLSN trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas SLSN's P/E ratio is 121.00. In terms of profitability, SKIN's ROE is -0.09%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, SKIN is more volatile compared to SLSN. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SLSN's competition here
SKIN vs GROV Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, GROV has a market cap of 49.6M. Regarding current trading prices, SKIN is priced at $0.62, while GROV trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas GROV's P/E ratio is -4.37. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV's competition here
SKIN vs AXIL Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, AXIL has a market cap of 46.2M. Regarding current trading prices, SKIN is priced at $0.62, while AXIL trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas AXIL's P/E ratio is 56.42. In terms of profitability, SKIN's ROE is -0.09%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, SKIN is more volatile compared to AXIL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check AXIL's competition here
SKIN vs UG Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, UG has a market cap of 32.9M. Regarding current trading prices, SKIN is priced at $0.62, while UG trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas UG's P/E ratio is 13.77. In terms of profitability, SKIN's ROE is -0.09%, compared to UG's ROE of +0.21%. Regarding short-term risk, SKIN is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UG's competition here
SKIN vs RAY Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, RAY has a market cap of 10.1M. Regarding current trading prices, SKIN is priced at $0.62, while RAY trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas RAY's P/E ratio is 5.00. In terms of profitability, SKIN's ROE is -0.09%, compared to RAY's ROE of +0.09%. Regarding short-term risk, SKIN is more volatile compared to RAY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check RAY's competition here
SKIN vs PHH Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, SKIN is priced at $0.62, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas PHH's P/E ratio is -0.53. In terms of profitability, SKIN's ROE is -0.09%, compared to PHH's ROE of +0.38%. Regarding short-term risk, SKIN is more volatile compared to PHH. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PHH's competition here
SKIN vs DSY Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, DSY has a market cap of 9.6M. Regarding current trading prices, SKIN is priced at $0.62, while DSY trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas DSY's P/E ratio is -0.23. In terms of profitability, SKIN's ROE is -0.09%, compared to DSY's ROE of +14.77%. Regarding short-term risk, SKIN is more volatile compared to DSY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check DSY's competition here
SKIN vs BRSH Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, SKIN is priced at $0.62, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas BRSH's P/E ratio is -0.01. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSH's competition here
SKIN vs MTEX Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, MTEX has a market cap of 8.6M. Regarding current trading prices, SKIN is priced at $0.62, while MTEX trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas MTEX's P/E ratio is -0.56. In terms of profitability, SKIN's ROE is -0.09%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, SKIN is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check MTEX's competition here
SKIN vs TANH Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, TANH has a market cap of 2.6M. Regarding current trading prices, SKIN is priced at $0.62, while TANH trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas TANH's P/E ratio is -0.03. In terms of profitability, SKIN's ROE is -0.09%, compared to TANH's ROE of +0.04%. Regarding short-term risk, SKIN is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check TANH's competition here
SKIN vs DSYWW Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, DSYWW has a market cap of 1.1M. Regarding current trading prices, SKIN is priced at $0.62, while DSYWW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas DSYWW's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, SKIN is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check DSYWW's competition here
SKIN vs TKLF Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, TKLF has a market cap of 905.8K. Regarding current trading prices, SKIN is priced at $0.62, while TKLF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas TKLF's P/E ratio is 1.95. In terms of profitability, SKIN's ROE is -0.09%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to TKLF. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check TKLF's competition here
SKIN vs BRSHW Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, SKIN is priced at $0.62, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas BRSHW's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSHW's competition here
SKIN vs GROV-WT Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.62, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV-WT's competition here
SKIN vs REV Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, REV has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.62, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas REV's P/E ratio is -1.19. In terms of profitability, SKIN's ROE is -0.09%, compared to REV's ROE of +0.89%. Regarding short-term risk, SKIN is more volatile compared to REV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check REV's competition here
SKIN vs SUMR Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.62, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas SUMR's P/E ratio is -3.66. In terms of profitability, SKIN's ROE is -0.09%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, SKIN is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SUMR's competition here
SKIN vs RDEN Comparison May 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 83.4M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.62, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.95, whereas RDEN's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, SKIN is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check RDEN's competition here